Hyperviscosity as a Complication in a Variety of Disorders

ABSTRACT

For a considerable time, hyperviscosity syndrome has been widely recognized as a serious manifestation of polycythemia and plasma cell dyscrasia. In this article a number of conditions will be considered in which the association with hyperviscosity has been more recently recognized and is less widely known. These conditions are hyperleukocytosis, retinoic acid therapy, and connective tissue disease such as rheumatoid arthritis. The essential problems in the first two are the hugely elevated white cell count (WCC) and the mechanical properties of the leukocytes, in other words, their relatively poor deformability and their adhesiveness for the endothelium. In the last, the essential problem is hugely elevated plasma viscosity due to immunocomplexes. They lead to increased flow resistance, especially in the microvessels, abnormal flow, and significant clinical symptoms. The details of the causes of the hyperviscosity, the symptoms that result, and the forms of treatment are discussed.

KEYWORDS

Hyperleukocytosis - hyperviscosity - leukostasis - retinoic acid - rheumatoid arthritis

REFERENCES

• 1 Somer T, Meiselman H J. Disorders of blood viscosity.  Ann Med . 1993;  25 31-39
• 2 Pearson T C. Rheology of polycythemias. In: Lowe GDO, ed. Clinical Blood Rheology, Vol II Boca Raton, FL: CRC Press 1988: 23-42
• 3 Somer T. Rheology of paraproteinaemias and the plasma hyperviscosity syndrome.  Baillieres Clin Haematol . 1987;  1 695-723
• 4 Lichtman M A, Rowe J M. Hyperleukemias: rheological, clinical and therapeutic considerations.  Blood . 1982;  60 279-283
• 5 Chien S, Usami S, Dellenback R J, Gregersen M I. Blood viscosity: influence of erythrocyte deformation.  Science . 1967;  157 827-829
• 6 Young T-H, Cuttner J, Meyer R, Chien, S. Leukapheresis reduced blood viscosity in chronic myelogenous leukemia patients with hyperleukocytosis.  Clin Hemorheol . 1990;  10 191-203
• 7 Chien S. White blood cell rheology. In: Lowe GDO, ed. Clinical Blood Rheology, Vol II Boca Raton, FL: CRC Press 1988: 87-110
• 8 Lichtman M A. Rheology of leukocytes, leukocyte suspensions and blood in leukemia: possible relationship to clinical manifestations.  J Clin Invest . 1973;  52 350-358
• 9 Ernst E, Hammerschmidt D E, Bagge U, Matrai A, Dormandy J A. Leukocytes and the risk of ischaemic diseases.  JAMA . 1987;  257 2318-2324
• 10 Lichtman M A, Kearney G A. The filterability of normal and leukemic leukocytes.  Blood Cells . 1976;  2 491-498
• 11 Roath S, Davenport P. Leucocyte numbers and quality: their effect on viscosity.  Clin Lab Haematol . 1991;  13 255-262
• 12 Preston F E, Sokol R J, Lilleyman J S, Winfield D A, Blackburn E K. Cellular hyperviscosity as a cause of neurological symptoms in leukaemia.  BMJ . 1978;  1 467-478
• 13 Tooke J E, Milligan D W. Capillary flow velocity in leukaemia.  BMJ . 1983;  286 518-519
• 14 Grant L. The sticking and emigration of white blood cells in inflammation. In: Zweifach BW, Grant L, McCluskey RT, eds. The Inflammatory Process, Vol II New York: Academic Press 1973: 205-249
• 15 House S D, Lipowsky H H. Leukocyte-endothelium adhesion: microhemodynamics in mesentery of cat.  Microvasc Res . 1987;  34 363-379
• 16 Kwaan H C, Bongu A. The hyperviscosity syndromes.  Semin Thromb Hemost . 1991;  25 199-208
• 17 McGee L C, Collins R D. Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia.  Medicine . 1974;  53 463-478
• 18 Harris A L. Leukostasis associated with blood transfusion in acute myeloid leukaemia.  BMJ . 1978;  2 1169-1171
• 19 Steinhardt G F, Steinhardt E. Priapism in children with leukemia.  Urology . 1981;  18 604-606
• 20 Lichtman M A, Heal J, Rowe J M. Hyperleukocytic leukaemia: rheological, clinical features and management.  Baillieres Clin Haematol . 1987;  1 725-746
• 21 Cuttner J, Holland J F, Norton L. Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia.  Med Pediatr Oncol . 1983;  11 76-78
• 22 Berg J, Vincent P C, Gunz F W. Effects of hydroxyurea and prognosis of newly diagnosed patients with acute non-lymphocytic leukemia.  Med J Aust . 1979;  1 480-482
• 23 Harris M. Leukostatsis associated with blood transfusion in acute myeloid leukaemia.  BMJ . 1978;  1 1169-1171
• 24 Chim C S, Kwong Y L, Liang R. et al . All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).  Hematol Oncol . 1996;  14 147-154
• 25 Frankel S R, Eardley A, Lauwers G, Weiss M, Warrell R P. The "retinoic acid syndrome" in acute promyelocytic leukemia.  Ann Intern Med . 1992;  117 292-296
• 26 Hickstein D D, Hickey M J, Collins S J. Transcriptional translation of the leukocyte adherence protein beta subunit during human myeloid cell differentiation.  J Biol Chem . 1988;  263 1363-1367
• 27 Cryer P E, Kissane J M. Rheumatoid arthritis with Felty's syndrome, hyperviscosity and immunologic hyperreactivity.  Am J Med . 1981;  70 89-101
• 28 Lowe G DO. Rheology of disease. In: Lowe GDO, ed. Clinical Blood Rheology, Vol II. Boca Raton, FL: CRC Press 1988: 89-111
• 29 Newton P, Taberner D A. Blood viscosity in rheumatoid arthritis.  Thromb Haemost . 1985;  54 308-312
• 30 Zakzook S I, Yunus M B, Mulconrey D S. Hyperviscosity syndrome in rheumatoid arthritis with Felty's syndrome: case report and review of literature.  Clin Rheumatol . 2002;  2 182-185
• 31 Eaton A M, Serota H, Kernodle G W. et al . Pulmonary hypertension secondary to serum hyperviscosity in a patient with rheumatoid arthritis.  Am J Med . 1987;  82 1039-1045
• 32 Morris L F, Lemak N A, Arnett F C, Jordon R E, Duvic M. Systemic lupus erythmatosus diagnosed during interferon alfa therapy.  South Med Assoc J . 1996;  89 810-814
• 33 Dwosh I L, Giles A R, Ford P M, Pater J L, Anastassiades T P. Plasmapheresis therapy in rheumatoid arthritis.  N Engl J Med . 1983;  308 1124-1129
• 34 Shumak K H, Rock G A. Therapeutic plasma exchange.  N Engl J Med . 1984;  310 762-771
• 35 Rampling M W. Red cell aggregation and yield stress. In: Lowe GDO, ed. Clinical Blood Rheology, Vol II. Boca Raton, FL; CRC Press 1988: 45-64
• 36 Cable M, Meiselman H J, Popel A S, Johnson, P C. Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle.  Am J Physiol . 1997;  273 H1020-H1032
• 37 Cokelet G R, Goldsmith H L. Decreased hemodynamic resistance in the two-phase flow of blood through small vertical tubes at low flow rates.  Circ Res . 1991;  64 1-17